Consensus Statement of the European Group on Graves' Orbitopathy (EUGOGO) on Management of Graves' Orbitopathy

Bartalena, Luigi, Baldeschi, Lelio, Dickinson, Alison J., Eckstein, Anja, Kendall-Taylor, Pat, Marcocci, Claudio, Mourits, Maarten P., Perros, Petros +20 more·2008·Thyroid
DOI 10.1089/thy.2007.0315

Cited by (405)

Items 201–300 of 405

  1. Treatment of mild to moderate Graves' ophthalmopathy with sodium diclofenac: a pilot study
    WALTER BLOISE, Lídia Y. Mimura, Janete P. Moura, Wilian Nicolau · 2011 · Arquivos Brasileiros de Endocrinologia & Metabologia
  2. What's in a name? Eponyms in head and neck imaging
    Jenny K. Hoang, James D. Eastwood, Christine M. Glastonbury · 2009 · Clinical Radiology
  3. Common Immunosuppressive Monotherapy for Graves’ Ophthalmopathy: A Meta-Analysis
    Pei Mou, Lihong Jiang, Yun Zhang, Yuzhen Li, Heng Lou, Chengcheng Zeng, Qiuhong Wang, Jin-Wei Cheng, Rui-Li Wei · 2015 · PLoS ONE
  4. Medial and mediolateral orbital decompression in intractable Graves’ Orbitopathy
    Ira Seibel, Veit M. Hofmann, Hasibe Sönmez, Shideh Schönfeld, Masen Dirk Jumah, Minoo Lenarz, Annekatrin Coordes · 2016 · Auris Nasus Larynx
  5. Serum microRNA as a potential biomarker for the activity of thyroid eye disease
    Namju Kim, Ho-Kyung Choung, Kwang Gi Kim, Sang Earn Woo, Min Kyu Yang, Sang In Khwarg, Min Joung Lee · 2023 · Scientific Reports
  6. Prise en charge diagnostique et thérapeutique d’une orbitopathie dysthyroïdienne : une affection multidisciplinaire
    Benjamin Leray, Philippe Imbert, D. Thouvenin, F Boutault, Philippe Jean Caron · 2013 · Journal Français d Ophtalmologie
  7. The Changes in Optic Nerve after Orbital Decompression Surgery for Thyroid Eye Disease and Case Reports of Ischemic Optic Neuropathy
    Yun Hsia, Chia‐Chieh Hsiao, Yi‐Hsuan Wei, I-Wen Lai, Chao‐Wen Lin, Shu‐Lang Liao · 2022 · BioMed Research International
  8. Prostaglandin analogue drops for the treatment of soft tissue expansion and exophthalmos in patients with inactive thyroid eye disease
    Maya Eiger‐Moscovich, Hadas Stiebel‐Kalish, Iftach Yassur, David Barash, Dan D. Gaton, Inbal Avisar · 2018 · Canadian Journal of Ophthalmology
  9. Metabolic Imbalance and Vitamin D Deficiency in Type 1 Diabetes in the Algerian Population
    Esma Mihoubi, Rachida Raache, Habiba Amroun, Malha Azzouz, Assia Galleze, Nesrine Zaabat, A. Aissou, Amina Ferhat, H. Sadi-Guettaf, Amel Boutemeur et al. · 2019 · Endocrine Metabolic & Immune Disorders - Drug Targets
  10. Endoscopic orbital fat decompression for the management of proptosis in Grave’s orbitopathy using a laryngeal skimmer blade
    David S. Curragh, Dinesh N. Selva · 2019 · Eye
  11. Doxycycline vs Placebo at 12 Weeks in Patients With Mild Thyroid-Associated Ophthalmopathy
    Yuan Pan, Yu-Xi Chen, Jian Zhang, Miaoli Lin, Guang‐Ming Liu, Xueliang Xu, Xianqun Fan, Yong Zhong, Qing Li, Siming Ai et al. · 2022 · JAMA Ophthalmology
  12. Treatment modalities of thyroid related orbitopathy
    Prem S. Subramanian, EricS Ahn · 2014 · Indian Journal of Ophthalmology
  13. Role of binding immunoglobulin protein (BiP) in Graves’ orbitopathy pathogenesis
    JaeSang Ko, Ji-Young Kim, Eun Jig Lee, Jin Sook Yoon · 2020 · Journal of Molecular Endocrinology
  14. Emerging pharmacotherapy for treatment of Graves’ disease
    Rebecca S. Bahn · 2012 · Expert Review of Clinical Pharmacology
  15. Elevated serum thyroid stimulating immunoglobulin linked to failure of first-line intravenous methylprednisolone monotherapy in moderate-to-severe thyroid eye disease
    Ofira Zloto, Arza Rosset, Ayelet Priel, Daphna Landau Prat, Tali Cukierman‐Yaffe, Ronen Shavit, Nancy Agmon‐Levin, Guy Ben Simon, Oded Sagiv · 2023 · Eye
  16. Static and dynamic pupillary features in graves’ ophthalmopathy
    Kübra Serbest Ceylanoğlu, Emine Malkoç Şen, Mehmet Ali Şekeroğlu · 2022 · Clinical and Experimental Optometry
  17. Orbital decompression surgery and horse chestnut seed extract improved superior orbital vein blood flow in patients with thyroid-associated ophthalmopathy
    Yujie Wu, Xin Wei, Manyi Xiao, Wei Xiong · 2016 · International Journal of Ophthalmology
  18. Oscillopsia After Isolated Lateral Wall Decompression Versus Balanced or 3-Wall Decompression
    Laura Porrúa-Tubío, Andrea Sales‐Sanz, Pablo de-Arriba-Palomero, Beatriz Félix-Espinar, Fernando de-Arriba-Palomero, Nieves Alonso-Formento, Ana Rosa Albandea, José María Rodríguez del Valle, Marco Sales‐Sanz · 2020 · Ophthalmic Plastic and Reconstructive Surgery
  19. Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial
    Peter Nicholas Taylor, Rathie Rajendram, Stephanie Jean Hanna, Victoria J. Wilson, Julie Pell, Chunhei Li, Anne E. Cook, Rao Gattamaneni, Nicholas P. Plowman, Sue Jackson et al. · 2023 · The Journal of Clinical Endocrinology & Metabolism
  20. Update on the medical treatment of Graves’ ophthalmopathy
    James Garrity · 2009 · International Journal of General Medicine
  21. The American Thyroid Association and American Association of Clinical Endocrinologists Guidelines for Hyperthyroidism and Other Causes of Thyrotoxicosis: An Appraisal
    Gilbert H. Daniels · 2011 · Endocrine Practice
  22. Radiotherapy for Graves’ disease. The possible role of low-dose radiotherapy
    Meritxell Arenas, S. Sabater, P. Lara Jiménez, Á. Rovirosa, Albert Biete, Victòria Linares, Montserrat Bellés, Julián Panés · 2016 · Reports of Practical Oncology & Radiotherapy
  23. 99Tcm-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy
    Bin Sun, Z Zhang, C Dong, Yanxia Zhang, Chunhong Yan, S Li · 2017 · Eye
  24. Socioeconomic Disparities in the Presentation and Treatment of Graves’ Disease and Thyroid Eye Disease
    Caroline W. Vargason, James G. Chelnis, Behin Barahimi, Louise A. Mawn · 2016 · Seminars in Ophthalmology
  25. The Changes in Ocular Biomechanical Response Parameters and Intraocular Pressure After Surgical Treatment for Thyroid Eye Disease
    Yun Hsia, Yi‐Hsuan Wei, Shu‐Lang Liao · 2023 · Investigative Ophthalmology & Visual Science
  26. Turbo Gradient and Spin-Echo BLADE-DWI for Extraocular Muscles in Thyroid-Associated Ophthalmopathy
    Qing Fu, Dingxi Liu, Hui Ma, Kun Zhou, Ting Yin, Chuansheng Zheng, Ziqiao Lei · 2023 · Journal of Clinical Medicine
  27. Orbital flourine-18-fluorodeoxyglucose positron emission tomography in patients with Graves’ disease for evaluation of active inflammation
    Lebriz Uslu, Levent Kabasakal, Sait Sağer, Erdoğan Cicik, Sertaç Asa, Kerim Sönmezoğlu · 2017 · Nuclear Medicine Communications
  28. Smoking effect on peripapillary and macular microvascular structure in inactive Graves’ ophthalmopathy
    Kübra Serbest Ceylanoğlu, Emine Malkoç Şen, Sibel Doğuizi, Gözde Hondur · 2021 · International Ophthalmology
  29. Guidelines for Radiographic Imaging of Cranial Neuropathies
    Aliasgher M. Khaku, Vijay A. Patel, Thomas T. Zacharia, David Goldenberg, Johnathan D. McGinn · 2017 · Ear Nose & Throat Journal
  30. Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public Involvement
    Petros Perros, Colin Mark Dayan, A. Jane Dickinson, Daniel G. Ezra, Janis L. Hickey, Christoph Hintschisch, George Jean Kahaly, John H. Lazarus, Marian Elizabeth Ludgate, Beate Bartès et al. · 2015 · Thyroid
  31. AI-based assessment of Clinical Activity Score and detection of active thyroid eye disease using facial images: validation of Glandy CAS
    Kyubo Shin, Jin Sook Yoon, Jongchan Kim, Jae Min Park, Hyun Young Park, Namju Kim, Min Joung Lee, Ho Kyung Choung, JaeSang Ko, Jae Hoon Moon · 2025 · BMJ Open Ophthalmology
  32. Clinical relevance of estimating circulating interleukin-17 and interleukin-23 during methylprednisolone therapy in Graves’ orbitopathy: A preliminary study
    Maria Kościuszko, Anna Popławska‐Kita, Przemysław Pawłowski, Danuta Lipińska, Justyna Hryniewicka, Dorota Jankowska, Maria Górska, Adam Jacek Kretowski, Janusz Myśliwiec · 2021 · Advances in Medical Sciences
  33. Network Meta-Analysis of Different Intravenous Glucocorticoid Regimes for the Treatment of Graves’ Orbitopathy
    Jun Jia, Jingjian Dong, Lin Deng · 2022 · Frontiers in Pharmacology
  34. Change in upper eyelid position after teprotumumab treatment for thyroid eye disease
    Tatiana R. Rosenblatt, Carolina A. Chiou, Michael K. Yoon, Nahyoung Grace Lee, Natalie Wolkow, Suzanne K. Freitag · 2024 · Orbit
  35. Tratamiento del hipertiroidismo por Enfermedad de Graves en pacientes adultos no embarazadas
    Ana Fadel A, Silvia Gutiérrez, José Luis Novelli, Ana María Orlandi, Ricardo Parma, María del Carmen Silva Croome, G. Chebel, Mayra Guardia, Paula Guido, María Gilligan et al. · 2013 · Revista Argentina de Endocrinología y Metabolismo
  36. Ocular treatment of thyroid eye disease
    Knut Eichhorn, Andrew R. Harrison, Erick D. Bothun, Linda K. McLoon, Michael S. Lee · 2010 · Expert Review of Ophthalmology
  37. The Role of FOXP3 Polymorphisms in Graves’ Disease with or without Ophthalmopathy in a Turkish Population
    Fulya Yaylacıoğlu Tuncay, Kübra Serbest Ceylanoğlu, Sezen Güntekin Ergün, Berçin Tarlan, Onur Konuk · 2024 · Turkish Journal of Ophthalmology
  38. Blood–aqueous barrier integrity in patients with Graves’ ophthalmopathy (GO), before and after rehabilitative surgery
    Anna Kłysik, Marcin Kozakiewicz · 2015 · Eye
  39. Thyroid Disease and the Nervous System
    James J. P. Alix, Pamela J. Shaw · 2014 · Elsevier eBooks
  40. Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves’ disease patients with thyrotoxic periodic paralysis
    Krittadhee Karndumri, Yotsapon Thewjitcharoen, Waralee Chatchomchuan, Sriurai Porramatikul, Sirinate Krittiyawong, Ekgaluck Wanothayaroj, Siriwan Butadej, Soontaree Nakasatien, Rajata Rajatanavin, Thep Himathongkam · 2020 · Journal of Clinical & Translational Endocrinology
  41. Serum T3 Level and Duration of Minimum Maintenance Dose Therapy Predict Relapse in Methimazole-Treated Graves Disease
    Yotsapon Thewjitcharoen, Krittadhee Karndumri, Waralee Chatchomchuan, Sriurai Porramatikul, Sirinate Krittiyawong, Ekgaluck Wanothayaroj, Siriwan Butadej, Soontaree Nakasatien, Rajata Rajatanavin, Thep Himathongkam · 2020 · Journal of the Endocrine Society
  42. Decreased serum level of IL-7 in patients with active Graves’ disease
    Ewelina Motylewska, Martyna Nieć, Agnieszka Siejka, Jan Komorowski, Hanna Ławnicka, Jacek Świętosławski, Henryk Stepien · 2015 · Cytokine
  43. The Influence of Juvenile Graves’ Ophthalmopathy on Graves’ Disease Course
    Jūratė Jankauskienė, Dalia Jarušaitienė · 2017 · Journal of Ophthalmology
  44. Orbital radiotherapy plus three-wall orbital decompression in a patient with rare ocular manifestations of thyroid eye disease: case report
    Shuo Zhang, Yang Wang, Sisi Zhong, Xingtong Liu, Yazhuo Huang, Sijie Fang, Ai Zhuang, Yinwei Li, Jing Ping Sun, Huifang Zhou et al. · 2018 · BMC Endocrine Disorders
  45. Polymorphisms of FAM167A-BLK Region Confer Risk of Autoimmune Thyroid Disease
    Ronghua Song, Qian Li, Xi Jia, Qiuming Yao, Bin Wang, Jin‐an Zhang · 2018 · DNA and Cell Biology
  46. Gravesʼ Orbitopathy: Current Concepts for Medical Treatment
    Michael Oeverhaus, Mareile Stöhr, Lars Christian Möller, Dagmar Führer, Anja Katrin Eckstein · 2021 · Klinische Monatsblätter für Augenheilkunde
  47. Teprotumumab for the treatment of thyroid eye disease
    Poupak Fallahi, Francesca Ragusa, Sabrina Rosaria Paparo, Giusy Elia, Eugenia Balestri, Valeria Mazzi, Armando Patrizio, Chiara Botrini, Salvatore Benvenga, Silvia Martina Ferrari et al. · 2023 · Expert Opinion on Biological Therapy
  48. Diagnostic precision in thyroid-associated ophthalmopathy using multi-center radiomics with 99mTc-DTPA SPECT/CT
    Jie Liu, Mengting Li, Hong Chen, Wei Liu, Mengmeng Hu, Fan Hu, Ling Ma, Shengqing Hu, Min Zhao, Wei Cao et al. · 2024 · Scientific Reports
  49. Effect of orbital radiotherapy on the outcome of surgical orbital decompression for thyroid-associated orbitopathy (TAO): a retrospective study in 136 patients
    Leïla Boulanouar, Solange Grunenwald, Philippe Imbert, Jonathan Khalifa, C. Dekeister, F Boutault, Philippe Jean Caron · 2019 · Endocrine
  50. Tirotoxicosis e hipertiroidismo
    Concepción Blanco Carrera, M. Cabañas-Durán, Castro Fernández, J.A. Rubio García · 2020 · Medicine - Programa de Formación Médica Continuada Acreditado
  51. Thyrotoxicosis
    Anthony Peter Weetman · 2009 · Medicine
  52. Rituximab for thyroid-associated ophthalmopathy
    Neda Minakaran, Rajni Jain, Jimmy M. Uddin, Daniel G. Ezra · 2011 · Cochrane Database of Systematic Reviews
  53. Dynamic Risk Model for the Medical Treatment of Graves’ Hyperthyroidism according to Treatment Duration
    Meihua Jin, Chae A Kim, Min Ji Jeon, Won Bae Kim, Tae Yong Kim, Won Gu Kim · 2024 · Endocrinology and Metabolism
  54. 37-Year-Old Woman With Palpitations and Fatigue
    Amit Noheria, Sahil Khanna, Colin P. West · 2010 · Mayo Clinic Proceedings
  55. Challenges of Managing Strabismus in Thyroid Eye Disease
    Mark D. Bailey, Rohini R. Sigireddi, Eric J. Kim, Kimberly G. Yen · 2021 · International Ophthalmology Clinics
  56. Clinical, Hormonal, and Ultrasound Characteristics of Patients with Newly Diagnosed Graves’ Disease And Different Thyroid Antibody Profiles
    R. Mekova, Mihail Boyanov · 2019 · Acta Medica Bulgarica
  57. Imaging Evaluation of the Orbit in Graves Ophthalmopathy.
    Teodor Sas, Georgiana-Cristiana Camen, A Stefanescu, Ioana Andreea GHEONEA · 2015 · Europe PMC (PubMed Central)
  58. An update on thyroid eye disease: Current knowledge, preferred practice patterns, and future therapies
    Fairooz Puthiyapurayil Manjandavida, Shaifali Chahar · 2020 · Kerala Journal of Ophthalmology
  59. Is radioiodine more likely than antithyroid drugs to worsen ophthalmopathy in patients with Graves disease?
    Rebecca S. Bahn · 2008 · Nature Clinical Practice Endocrinology &#38 Metabolism
  60. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves’ ophthalmopathy – a 1-year follow-up: study protocol for a randomized controlled trial
    Lindsay Hargitai, Philipp Riss, Julius Lukas, Alois Gessl, Daniela Dunkler, Shuren Li, Asha Leisser, Sandra Rezar‐Dreindl, Katharina Eibenberger, Andreas Selberherr et al. · 2018 · Trials
  61. Recent advances in thyroid eye disease: An overview
    Sahil Agrawal, Rajendra P Maurya, P R Ananya, Syeed Mehbub Ul Kadir, Virendra Pratap Singh, Deepsekhar Das, Saloni Gupta, Vibha Singh, Meghna Roy · 2021 · IP International Journal of Ocular Oncology and Oculoplasty
  62. Weight Gain after Treatment of Hyperthyroidism is Associated with Impairment of Quality of Life
    Angelos Kyriacou, Alexis Kyriacou, Demetris Lamnisos, Aliki Economides, Panayiotis Economides, Petros Perros, Akheel A. Syed · 2025 · Thyroid
  63. Global Trends in Eyelid Disease associated with Thyroid Ophthalmopathy (1975-2025): A Systematic Review and Meta-Analysis
    Niraj Kumar Yadav, Priyanka Sharma, Semone Singhal, Maya Hada, Meenakshi Wadhwani · 2026 · Journal of Ophthalmology and Advance Research
  64. AB1077 ANTI-IL6-RECEPTOR TOCILIZUMAB IN GRAVES' ORBITOPATHY. MULTICENTER STUDY OF 46 PATIENTS IN CLINICAL PRACTICE
    Belén Atienza‐Mateo, J. L. Martín-Varillas, Vanesa Calvo-Río, Rosalía Demetrio‐Pablo, Elia Valls Pascual, Beatriz Valls-Espinosa, Olga Maiz, Ana Blanco, Ignacio Torre-Salaberri, Verónica Rodríguez-Méndez et al. · 2019 · Annals of the Rheumatic Diseases
  65. Evaluation of corticoresistance in patients with thyroid eye disease and use of rituximab as a second-line treatment
    Klara Pekarova, Jan Schovánek, Roman Dohnal, Martin Radvanský, David Karásek, Marta Karhanová · 2024 · Endocrine
  66. Graves’ Ophthalmopathy
    Henry B. Burch, Rebecca S. Bahn · 2015 · Elsevier eBooks
  67. Hypo vs. hyperthyroid eye disease: is there any difference?
    Bahram Eshraghi, Mohsen Pourazizi, Maryam Abbasi, Iman Mohammadbeigy · 2023 · BMC Ophthalmology
  68. Evaluation of lamina cribrosa and peripapillary vascular density in thyroid orbitopathy and effect of intravenous methylprednisolone therapy
    Furkan Ozer, Metin Ünlü, Duygu Gülmez Sevim, Hidayet Şener, Cem Evereklioğlu · 2023 · Canadian Journal of Ophthalmology
  69. Graves’ ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature
    Ozan Cem Güler, Cem Önal, Güngör Arslan · 2015 · Wiener klinische Wochenschrift
  70. Safety of pulse therapy with glucocorticoid hormones in the treatment of endocrine orbitopathy
    М. С. Черенько · 2018 · Clinical endocrinology and endocrine surgery
  71. Extraocular Muscles Response to Neuromuscular Diseases and Specific Pathologies
    Fátima Pedrosa Domellöf · 2012 · Springer eBooks
  72. Current Trends in the Management of Thyroid Ophthalmopathy
    Sunah Kang, Ho‐Seok Sa · 2016 · Hanyang Medical Reviews
  73. Wcześniejsze leczenie choroby Gravesa lekami tyreostatycznymi lub radiojodem nie wpływa na skuteczność leczenia immunosupresyjnego orbitopatii tarczycowej
    Agnieszka Jagiełło-Korzeniowska, Andrzej Sokołowski, Anna Krzentowska, Grażyna Miklaszewska, Agata Bałdys‐Waligórska · 2016 · Endokrynologia Polska
  74. Changes of saccadic eye movements in thyroid‐associated ophthalmopathy
    Hermann Dieter Schworm, Roberto Bolzani, Mariagrazia Benassi, Leif Tallstedt, Agneta Rydberg, Gunnar Lennerstrand, Jan Ygge · 2011 · Acta Ophthalmologica
  75. Alteration of CXCL8 pathway in the ocular surface of patients with Graves' orbitopathy
    Alice Bruscolini, Marco Segatto, Marco Marenco, Alessandro Lambìase, Marta Sacchetti · 2020 · Autoimmunity Reviews
  76. Thyroid-related orbitopathy: clinical overview, novel medical treatments and the role of orbital surgery
    Federico Giannuzzi, Matteo Mario Carlà, Emanuele Crincoli, Gloria Gambini, Lorenzo Hu, Francesco Boselli, Giovanni Cuffaro, Claudio Parrilla, Mario Rigante, Monica Maria Pagliara et al. · 2025 · International Ophthalmology
  77. Caracterización de pacientes controlados por enfermedad de Basedow Graves en un hospital universitario
    Alejandra Lanas, PATRICIA V. DÍAZ, Daniela Eugenin, Franco González, Pía Cid, Francisco Cordero, Verónica Araya, Claudio Liberman, Marcela Barberán M., Patricio Gac et al. · 2017 · Revista médica de Chile
  78. Jod-Basedow phenomenon: Reactivation of thyroid eye disease after contrast computed tomography
    Roland Höllhumer, Francesca Indiveri · 2018 · African vision and eye health
  79. Role of Intravenous Methylprednisolone in Moderate to Severe Thyroid Associated Orbitopathy (Tao) in Indians: A Tertiary Care Institute Study
    Manpreet Singh · 2018 · Medical & Surgical Ophthalmology Research
  80. Efficacy and safety of tripterygium glycosides for active moderate to severe Graves’ ophthalmopathy: a randomised, observer-masked, single-centre trial
    Xiaozhen Ye, Heng Zhao, Jun Liu, Bin Lü, Jiaqing Shao, Jian Wang · 2020 · European Journal of Endocrinology · Retracted
  81. Immune Checkpoints and Graves’ Disease, Thyroid Eye Disease, and Orbital Myopathy: A Comprehensive Review
    Zahra Souri, Farzad Pakdel · 2024 · Journal of Ophthalmic and Vision Research
  82. Rituximab Treatment as Second-Line Therapy in Glucocorticoid Nonresponsive Graves' Orbitopathy: A Nonrandomized, Controlled, Interventional Study
    Sofia Manousou, Mats Holmberg, Elin Ekdahl, Helge Malmgren, Helena Filipsson Nyström · 2024 · Endocrine Practice
  83. Abordagem da orbitopatia associada à tiróide.
    Marta Alves, Celestino Neves, Davide Maurício Carvalho, José Luís Medina · 2012 · Acta Médica Portuguesa
  84. Accessory Lateral Rectus Muscle in Graves’ Orbitopathy: A Case Report
    Nicole Fichter, G. von Arx, E. C. Kirsch · 2013 · Clinical Neuroradiology
  85. Thyroid surgery for treatment of Graves’ disease complicated by ophthalmopathy: a comprehensive review
    Jordan Wong, Sam M. Wiseman · 2015 · Expert Review of Endocrinology & Metabolism
  86. Outcomes following orbital decompression surgery for dysthyroid optic neuropathy associated with Graves’ ophthalmopathy.
    Jerome How Ing Ha, James K. Leong, Peter A. Martin, Raf Ghabrial, Ross S. Benger · 2015 · Asian Journal of Ophthalmology
  87. Thyroidectomy for the treatment of Graves’ thyrotoxicosis in thioamide-induced agranulocytosis and sepsis
    Colin L. Knight, Shamil D. Cooray, Jaideep Kulkarni, Michael Borschmann, Mark A. Kotowicz · 2017 · Endocrinology Diabetes and Metabolism Case Reports
  88. Orbitadekompression
    Hans Jürgen Welkoborsky, Sylvia Katherina Graß, Julian Küstermeyer, Kim Vanessa Steinke · 2017 · HNO
  89. Orbital Decompression: Graded Surgical Approach
    Kyle J. Godfrey, Christine C. Annunziata, Bobby S. Korn, Don O. Kikkawa · 2018 · Springer eBooks
  90. Orbital Disease in Neuro-Ophthalmology
    Kenneth S. Shindler · 2018 · Elsevier eBooks
  91. Thyroid Eye Disease
    Ashley A. Campbell, Michael Kazim · 2019 · Springer eBooks
  92. Orbital disease in neuro-ophthalmology
    Grant T. Liu, Nicholas J. Volpe, Steven L. Galetta · 2010 · Elsevier eBooks
  93. Transnasal endoscopic orbital decompression in the algorithm of surgical treatment of endocrine ophthalmopathy
    Кочетков Петр Александрович, Yaroslav O. Grusha, Valeriy M. Svistushkin, Dilyara S. Ismailova, Natalya Yu. Sviridenko, E D Duvanova · 2022 · Russian Bulletin of Otorhinolaryngology
  94. Endokrine Orbitopathie: Aktueller Stand der medikamentösen Therapie
    Michael Oeverhaus, Mareile Stöhr, Lars Christian Möller, Dagmar Führer, Anja Katrin Eckstein · 2023 · Laryngo-Rhino-Otologie
  95. Interdisziplinäre Therapie der Erkrankungen der Orbita
    Anja Katrin Eckstein, Hans‐Jürgen Welkoborsky · 2024 · Laryngo-Rhino-Otologie
  96. Epidemiology and Genetic Factors in Graves’ Disease and Graves’ Ophthalmopathy
    Sara Salehi Hammerstad, Yaron Tomer · 2015 · Springer eBooks
  97. Patient Management in Clinical Practice
    Timothy H. M. Fung, Winfried M. K. Amoaku · 2020 · Springer eBooks
  98. Autoimmune Thyroid Disease
    Jessica R. Smith, Stephen A. Huang · 2018 · Springer eBooks
  99. Thyroid associated orbitopathy: Understanding pathophysiology
    Imtiaz A. Chaudhry · 2010 · Saudi Journal of Ophthalmology
  100. Thyroid Eye Disease
    M. Tariq Bhatti, Jonathan J. Dutton · 2014 · Journal of Neuro-Ophthalmology